tiprankstipranks
Trevi Therapeutics Inc (TRVI)
NASDAQ:TRVI
US Market
Holding TRVI?
Track your performance easily

Trevi Therapeutics (TRVI) Income Statement

347 Followers

Trevi Therapeutics Income Statement

Last quarter (Q3 2024), Trevi Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Trevi Therapeutics's net income was $-13.24M. See Trevi Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 48.22M$ 33.92M$ 29.91M$ 32.48M$ 32.49M$ 26.64M
Operating Income
$ -48.22M$ -33.92M$ -29.91M$ -32.48M$ -32.49M$ -26.64M
Net Non Operating Interest Income Expense
$ 3.89M$ 4.36M$ 577.00K$ -1.19M$ -278.00K$ 577.00K
Other Income Expense
$ 652.00K$ 469.00K$ 142.00K$ 293.00K$ 9.00K-
Pretax Income
$ -44.35M$ -29.10M$ -29.19M$ -33.96M$ -32.78M$ -26.07M
Tax Provision
$ -29.00K$ -32.00K$ -36.00K$ -21.00K$ -18.00K$ -18.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -44.32M$ -29.07M$ -29.15M$ -33.94M$ -32.76M$ -26.75M
Basic EPS
$ -0.44$ -0.29$ -0.45$ -1.49$ -1.81-
Diluted EPS
$ -0.44$ -0.29$ -0.45$ -1.49$ -1.81$ -2.28
Basic Average Shares
$ 401.34M$ 99.03M$ 64.54M$ 22.84M$ 18.06M$ 11.74M
Diluted Average Shares
$ 401.34M$ 99.03M$ 64.54M-$ 18.06M$ 11.74M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 48.22M$ 33.92M$ 29.91M$ 32.48M$ 32.49M$ 26.64M
Net Income From Continuing And Discontinued Operation
$ -44.32M$ -29.07M$ -29.15M$ -33.94M$ -32.76M$ -26.05M
Normalized Income
$ -31.84M$ -29.13M-$ -33.98M--
Interest Expense
------
EBIT
$ -44.34M$ -28.71M$ -28.02M$ -32.76M$ -32.32M$ -26.07M
EBITDA
$ -43.67M$ -28.58M$ -27.98M$ -32.71M$ -32.27M$ -26.03M
Currency in USD

Trevi Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis